Subtype
Adult Infiltrating Astrocytic Tumor
CI-CAN-00004379Explore in graph →
Non-malignant22 active trials
- NCIt
- C8289
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00004379Explore in graph →
Clinical trials
145 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02613988 | Advanced MR Imaging as Predictor of Treatment Response in Newly Diagnosed Glioblastomas | unknown | N/A | 100 | Asan Medical CenterOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT05333588 | The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme. | unknown | Early Phase 1 | 20 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Apr 19, 2022 | clinicaltrials |
| NCT03025893 |
| A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme(STELLAR) |
| unknown |
| Phase 2 / Phase 3 |
| 100 |
| Amsterdam UMC, location VUmcOTHER |
| 1 |
| Apr 19, 2021 |
| clinicaltrials |
Data updated 23 days agoSource updated May 14, 2024source: clinicaltrials